Table of Contents
Print

What is the SNAP‑25 gene and its relevance to ADHD? 

The SNAP‑25 gene ADHD connection has become a major focus in neurogenetics, and for good reason. SNAP‑25 plays a critical role in neurotransmitter release, helping nerve cells communicate effectively. In ADHD, where brain signalling can be disrupted, variations in this gene may influence how symptoms present and respond to treatment. 

SNAP‑25 is part of a protein complex involved in the “snap” of synaptic transmission, essentially how messages get from one neuron to another. Changes or mutations in this gene can affect synaptic plasticity, or the brain’s ability to adapt and reorganise connections. In children and adults with ADHD, reduced plasticity could explain challenges in learning, memory, and behavioural regulation. 

Why SNAP‑25 Matters in Brain Function and ADHD 

Here is how variations in the SNAP‑25 gene may influence key brain processes tied to ADHD symptoms: 

Impaired brain signalling  

SNAP‑25 variants may reduce the efficiency of neurotransmitter release, particularly dopamine, a chemical essential for attention and motivation. This disruption can intensify symptoms like inattention and impulsivity. Treatments that boost dopamine signalling, such as stimulant medications, may help compensate for this deficit. 

Altered synaptic plasticity  

Poor adaptability in neural circuits may make it harder for people with ADHD to adjust behaviour or focus during changing situations. SNAP‑25-linked differences in plasticity may underlie the difficulty in shifting attention or maintaining emotional regulation. Cognitive training and behavioural therapies can improve these skills over time. 

Potential for personalised treatment  

Understanding whether SNAP‑25 variants are present could one day guide more tailored treatment plans including the choice of medication and therapy type based on individual genetic profiles. 

Visit providers like ADHD Certify for personal consultations that consider your neurogenetic profile.

For a deeper dive into the science, diagnosis, and full treatment landscape, read our complete guide to Genetic studies and biomarkers.

Victoria Rowe, MSc, author for my patient advice - mypatientadvice.co.uk

Victoria Rowe, MSc

Author

Victoria Rowe is a health psychologist with a Master’s in Health Psychology and a BS in Applied Psychology. She has experience as a school psychologist, conducting behavioural assessments, developing individualized education plans (IEPs), and supporting children’s mental health. Dr. Rowe has contributed to peer-reviewed research on mental health, including studies on anxiety disorders and the impact of COVID-19 on healthcare systems. Skilled in SPSS, Minitab, and academic writing, she is committed to advancing psychological knowledge and promoting well-being through evidence-based practice.

All qualifications and professional experience stated above are authentic and verified by our editorial team. However, pseudonym and image likeness are used to protect the author's privacy. 

Dr. Rebecca Fernandez, MBBS, author and a reviewer for my patient advice - mypatientadvice.co.uk

Dr. Rebecca Fernandez, MBBS

Reviewer

Dr. Rebecca Fernandez is a UK-trained physician with an MBBS and experience in general surgery, cardiology, internal medicine, gynecology, intensive care, and emergency medicine. She has managed critically ill patients, stabilised acute trauma cases, and provided comprehensive inpatient and outpatient care. In psychiatry, Dr. Fernandez has worked with psychotic, mood, anxiety, and substance use disorders, applying evidence-based approaches such as CBT, ACT, and mindfulness-based therapies. Her skills span patient assessment, treatment planning, and the integration of digital health solutions to support mental well-being.

All qualifications and professional experience stated above are authentic and verified by our editorial team. However, pseudonym and image likeness are used to protect the reviewer's privacy.